In this study, we demonstrated that dysregulation of apoptotic signaling, particularly through the PUMA–p53 axis, and increased proliferative activity, marked by Ki-67 overexpression, are independently associated with adverse outcomes in colorectal cancer. The gene discussed is TP53; the disease is colorectal cancer.